Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes

Thomas Blom, Rutger Meinsma, Franca di Summa, Emile van den Akker, André B.P. van Kuilenburg, Marten Hansen, Godelieve A.M. Tytgat

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes'. Together they form a unique fingerprint.

Medicine & Life Sciences